Transgene Biotek Quarterly Results for Trading Insights
In Sept 2025, Transgene Biotek (TRABI) reported revenue ₹0 Cr and net profit ₹0 Cr. For annual financials, live price and key ratios, visit TRABI stock live price.
TRABI Quarterly Results — Revenue, Profit & EPS Highlights
Transgene Biotek latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Compare with TRABI fair value to assess whether the stock is under or overvalued.
- Net Profit of ₹-1 Cr in Mar 2025 (+0.0% vs Mar 2025)
- EBITDA of ₹-1 Cr in Mar 2025 (+0.0% vs Mar 2025)
- Operating Margin of -675.0% in Mar 2025 (+0.0pp vs Mar 2025)
- Earnings Per Share of ₹-0.09 in Mar 2025 (+0.0% vs Mar 2025)
Transgene Biotek Quarterly Results — Revenue, EBITDA, Net Profit & EPS
TRABI quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 0 | 0 | 0 | 0 | 0 | - | - |
| Net Profit (₹ Cr) | 0 | -1 | 0 | 0 | 0 | - | - |
| EBITDA (₹ Cr) | 0 | -1 | 0 | 0 | 0 | - | - |
| EPS (₹) | -0.05 | -0.09 | -0.06 | -0.05 | -0.01 | - | - |
| Operating Margin (%) | -160.0% | -675.0% | -280.0% | -120.0% | -133.0% | - | - |
TRABI Share Price Trend — 1-Year Movement Across Quarterly Results
Transgene Biotek 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Analyse TRABI ownership pattern to track promoter, FII and institutional holdings.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
TRABI vs Healthcare Services Peers — Quarterly Revenue, Profit & Market Cap
Transgene Biotek latest quarter revenue and net profit vs Healthcare Services competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Apollo Hospitals
Sept 2025 |
₹108,075.74 Cr | 7516.5 | 6,365 | 494 | +12.4% | - | 7.8% | 226.5 |
|
Max Healthcare Inst…
Sept 2025 |
₹92,773.83 Cr | 951.7 | 2,168 | 491 | +10.8% | - | 22.6% | 188.5 |
|
Fortis Healthcare
Sept 2025 |
₹64,009.13 Cr | 850.3 | 2,381 | 329 | +17.2% | - | 13.8% | 199.6 |
|
Narayana Hrudayalaya
Sept 2025 |
₹35,863.28 Cr | 1768.3 | 1,668 | 259 | +11.0% | - | 15.5% | 139.0 |
|
Aster DM Healthcare
Sept 2025 |
₹35,325.49 Cr | 666.1 | 1,226 | 121 | +18.8% | - | 9.9% | 312.7 |
All amounts in ₹ Crores